Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

This study has been completed.
Sponsor:
Information provided by:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00043927
First received: August 14, 2002
Last updated: August 20, 2013
Last verified: August 2013
  Purpose

This study will gather and compare data about the effectiveness and safety of two different treatments for extensive Small Cell Lung Cancer (SCLC) in patients who have not received previous chemotherapy. One treatment will use an investigational drug in combination with an FDA approved chemotherapy. The other treatment will use a combination of two FDA approved chemotherapy drugs.


Condition Intervention Phase
Small Cell Lung Cancer
Drug: topotecan/cisplatin
Drug: etoposide/cisplatin
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin as Treatment for Chemotherapy-naive Patients With Extensive Disease-Small Cell Lung Cancer.

Resource links provided by NLM:


Further study details as provided by GlaxoSmithKline:

Primary Outcome Measures:
  • Overall Survival

Secondary Outcome Measures:
  • response rates, response duration, time to progression, tolerability and patient-perceived disease status and well being for patients

Estimated Enrollment: 760
Study Start Date: April 2001
Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Written informed consent (patient's written understanding of and agreement to participate in this study).
  • Patients with confirmed extensive small cell lung cancer (SCLC).
  • No prior chemotherapy within 5 years of the diagnosis of SCLC.
  • Presence of either measurable or non-measurable SCLC by X-ray or physical examination.
  • At least 3 weeks since last major surgery (a lesser period is acceptable if decided to be in the best interest of the patient).
  • At least 24 hours since prior radiotherapy. Patients who have received radiotherapy must have recovered from any reversible side effects, such as nausea and vomiting.
  • Laboratory criteria: Patients must have adequate bone marrow reserve and adequate kidney and liver function.

Exclusion Criteria:

  • Symptoms of spreading of the disease to the brain that requires treatment with drugs called steroids.
  • Any active infection.
  • Severe medical problems other than the diagnosis of SCLC, that would limit the ability of the patient to follow study guidelines or that would expose the patient to extreme risk.
  • Ongoing or planned chemotherapy, immunotherapy, radiotherapy, or investigational therapy for the treatment of SCLC.
  • Use of an investigational drug within 30 days before the first dose of study medication.
  • Women who are pregnant or lactating.
  • Patients of child-bearing potential who refuse to practice an adequate form of birth control.
  • Patients with clinical evidence of any stomach or intestinal (GI) condition.
  • Patients requiring treatment with the drug cyclosporin A.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00043927

  Hide Study Locations
Locations
United States, Alabama
GSK Clinical Trials Call Center
Hoover, Alabama, United States, 35216
United States, California
GSK Clinical Trials Call Center
Chula Vista, California, United States, 91911
GSK Clinical Trials Call Center
Fountain Valley, California, United States, 92708
GSK Clinical Trials Call Center
Greenbrae, California, United States, 94904
GSK Clinical Trials Call Center
Poway, California, United States, 92064
GSK Clinical Trials Call Center
Rancho Mirage, California, United States, 92270
GSK Clinical Trials Call Center
Sacramento, California, United States, 95816-5616
GSK Clinical Trials Call Center
San Diego, California, United States, 92102-8421
GSK Clinical Trials Call Center
San Diego, California, United States, 92121
GSK Clinical Trials Call Center
Soquel, California, United States, 95073
GSK Clinical Trials Call Center
Vista, California, United States, 92083
United States, Colorado
GSK Clinical Trials Call Center
Colorado Springs, Colorado, United States, 80909
United States, Connecticut
GSK Clinical Trials Call Center
Norwich, Connecticut, United States, 06360
United States, District of Columbia
GSK Clinical Trials Call Center
Washington, District of Columbia, United States, 20307-5001
United States, Florida
GSK Clinical Trials Call Center
Gainesville, Florida, United States, 32610
GSK Clinical Trials Call Center
Miami Shores, Florida, United States, 33138
GSK Clinical Trials Call Center
Ocala, Florida, United States, 34471
GSK Clinical Trials Call Center
Pensacola, Florida, United States, 32501
GSK Clinical Trials Call Center
Tarpon Springs, Florida, United States, 34689
United States, Georgia
GSK Clinical Trials Call Center
Atlanta, Georgia, United States, 30328
GSK Clinical Trials Call Center
Atlanta, Georgia, United States, 30335
GSK Clinical Trials Call Center
Atlanta, Georgia, United States, 30030
GSK Clinical Trials Call Center
Atlanta, Georgia, United States, 30308
GSK Clinical Trials Call Center
Augusta, Georgia, United States, 30912
GSK Clinical Trials Call Center
Cummings, Georgia, United States, 30040
GSK Clinical Trials Call Center
Decatur, Georgia, United States, 30033
United States, Illinois
GSK Clinical Trials Call Center
Aurora, Illinois, United States, 60506
GSK Clinical Trials Call Center
Chicago, Illinois, United States, 60637-1470
GSK Clinical Trials Call Center
Chicago, Illinois, United States, 60612
GSK Clinical Trials Call Center
Elk Grove Village, Illinois, United States, 60007
GSK Clinical Trials Call Center
Park Ridge, Illinois, United States, 60068
United States, Indiana
GSK Clinical Trials Call Center
Evansville, Indiana, United States, 47713
GSK Clinical Trials Call Center
South Bend, Indiana, United States, 46601
United States, Louisiana
GSK Clinical Trials Call Center
New Orleans, Louisiana, United States, 70112
GSK Clinical Trials Call Center
Shreveport, Louisiana, United States, 71103
United States, Maryland
GSK Clinical Trials Call Center
Frederick, Maryland, United States, 21701
United States, Massachusetts
GSK Clinical Trials Call Center
Pittsfield, Massachusetts, United States, 01201
United States, Minnesota
GSK Clinical Trials Call Center
Minneapolis, Minnesota, United States, 55404
United States, Missouri
GSK Clinical Trials Call Center
St. Louis, Missouri, United States, 63141
United States, Nevada
GSK Clinical Trials Call Center
Reno, Nevada, United States, 89502
United States, New Jersey
GSK Clinical Trials Call Center
Voorhees, New Jersey, United States, 08043
United States, New Mexico
GSK Clinical Trials Call Center
Albuquerque, New Mexico, United States, 87109
United States, New York
GSK Clinical Trials Call Center
Albany, New York, United States, 12208
GSK Clinical Trials Call Center
New York, New York, United States, 10021
GSK Clinical Trials Call Center
New York, New York, United States, 10032
GSK Clinical Trials Call Center
Rochester, New York, United States, 14623
GSK Clinical Trials Call Center
Valhalla, New York, United States, 10595
United States, North Dakota
GSK Clinical Trials Call Center
Bismarck, North Dakota, United States, 58501
United States, Ohio
GSK Clinical Trials Call Center
Cleveland, Ohio, United States, 44106-5065
GSK Clinical Trials Call Center
Columbus, Ohio, United States, 43222
United States, Oregon
GSK Clinical Trials Call Center
Portland, Oregon, United States, 97232-2099
United States, Pennsylvania
GSK Clinical Trials Call Center
Lemoyne, Pennsylvania, United States, 17043
GSK Clinical Trials Call Center
Limerick, Pennsylvania, United States, 19468
GSK Clinical Trials Call Center
Philadelphia, Pennsylvania, United States, 19140
United States, South Carolina
GSK Clinical Trials Call Center
Columbia, South Carolina, United States, 29203
GSK Clinical Trials Call Center
Spartanburg, South Carolina, United States, 29303
United States, Tennessee
GSK Clinical Trials Call Center
Memphis, Tennessee, United States, 38119
United States, Texas
GSK Clinical Trials Call Center
Fort Worth, Texas, United States, 76104
GSK Clinical Trials Call Center
Houston, Texas, United States, 77060
United States, Virginia
GSK Clinical Trials Call Center
Abingdon, Virginia, United States, 24211
GSK Clinical Trials Call Center
Norfolk, Virginia, United States, 23502
United States, Washington
GSK Clinical Trials Call Center
Olympia, Washington, United States, 98506
GSK Clinical Trials Call Center
Yakima, Washington, United States, 98902
United States, West Virginia
GSK Clinical Trials Call Center
Morgantown, West Virginia, United States, 26506
United States, Wisconsin
GSK Clinical Trials Call Center
Madison, Wisconsin, United States, 53792
United States, Wyoming
GSK Clinical Trials Call Center
Laramie, Wyoming, United States, 82070
Austria
GSK Clinical Trials Call Center
Vienna, Austria, A-1090
GSK Clinical Trials Call Center
Vienna, Austria, A-1130
GSK Clinical Trials Call Center
Vienna, Austria, A-1140
Belgium
GSK Clinical Trials Call Center
Charleroi, Belgium, 6000
GSK Clinical Trials Call Center
Edegem, Belgium, 2650
GSK Clinical Trials Call Center
Haine-Saint- Paul, Belgium, 7100
GSK Clinical Trials Call Center
Leuven, Belgium, 3000
GSK Clinical Trials Call Center
Liege, Belgium, 4000
GSK Clinical Trials Call Center
Luxembourg, Belgium, 1210
Brazil
GSK Clinical Trials Call Center
Belo Horizonte, Brazil, 30140-083
GSK Clinical Trials Call Center
Caxias do Sul, Brazil, 95010-060
GSK Clinical Trials Call Center
Fortaleza, Brazil, 60430-230
GSK Clinical Trials Call Center
Porto Alegre, Brazil, 90035-003
GSK Clinical Trials Call Center
Porto Alegre, Brazil, 90020-090
GSK Clinical Trials Call Center
Rio de Janeiro, Brazil, 20230-130
GSK Clinical Trials Call Center
Salvador, Brazil, 41920-000
GSK Clinical Trials Call Center
Sao Paulo, Brazil, 04023-062
GSK Clinical Trials Call Center
Sao Paulo, Brazil, 05403-900
Bulgaria
GSK Clinical Trials Call Center
Bourgas, Bulgaria, 8000
GSK Clinical Trials Call Center
Plovdiv, Bulgaria, 4000
GSK Clinical Trials Call Center
Sofia, Bulgaria, 1000/1527
GSK Clinical Trials Call Center
Sofia, Bulgaria, 1156
GSK Clinical Trials Call Center
Varna, Bulgaria, 9010
Canada, Alberta
GSK Clinical Trials Call Center
Calgary, Alberta, Canada, T2N 4N2
GSK Clinical Trials Call Center
Edmonton, Alberta, Canada, T6G 1E2
Canada, Manitoba
GSK Clinical Trials Call Center
Winnipeg, Manitoba, Canada, R3E 0V9
Canada, Nova Scotia
GSK Clinical Trials Call Center
Sydney, Nova Scotia, Canada, B1P 1P3
Canada, Ontario
GSK Clinical Trials Call Center
Newmarket, Ontario, Canada, L3Y 2P9
GSK Clinical Trials Call Center
Oshawa, Ontario, Canada, L1G 2B9
GSK Clinical Trials Call Center
Ottawa, Ontario, Canada, K1H 1C4
GSK Clinical Trials Call Center
Peterborough, Ontario, Canada, K9H 7B6
GSK Clinical Trials Call Center
Sault Sainte Marie, Ontario, Canada, P6B 1Y5
GSK Clinical Trials Call Center
Thunder Bay, Ontario, Canada, P7B 6V4
GSK Clinical Trials Call Center
Toronto, Ontario, Canada, M5G 2M9
GSK Clinical Trials Call Center
Weston, Ontario, Canada, M9N 1N8
Canada, Quebec
GSK Clinical Trials Call Center
Greenfield Park, Quebec, Canada, J4V 2H1
GSK Clinical Trials Call Center
Montreal, Quebec, Canada, H1T 2M4
GSK Clinical Trials Call Center
Montreal, Quebec, Canada, H2L 4M1
GSK Clinical Trials Call Center
Montreal, Quebec, Canada, H3T 1E2
GSK Clinical Trials Call Center
Sainte-Foy, Quebec, Canada, G1V 4G5
Chile
GSK Clinical Trials Call Center
Santiago, Chile
China
GSK Clinical Trials Call Center
Beijing, China, 100036
GSK Clinical Trials Call Center
Shanghai, China, 200433
GSK Clinical Trials Call Center
Wangfujing, China, 100730
GSK Clinical Trials Call Center
Xian, China, 710061
Costa Rica
GSK Clinical Trials Call Center
San Jose, Costa Rica
Czech Republic
GSK Clinical Trials Call Center
Hradec Kralove, Czech Republic, 500 05
GSK Clinical Trials Call Center
Olomouc, Czech Republic, 775 25
GSK Clinical Trials Call Center
Plzen, Czech Republic, 305 99
GSK Clinical Trials Call Center
Praha, Czech Republic, 150 05
GSK Clinical Trials Call Center
Praha, Czech Republic, 121 00
Estonia
GSK Clinical Trials Call Center
Tallinn, Estonia, 11619
Finland
GSK Clinical Trials Call Center
Helsinki, Finland, 29
GSK Clinical Trials Call Center
Kangasala, Finland, 36280
GSK Clinical Trials Call Center
Oulu, Finland, 90029
France
GSK Clinical Trials Call Center
Caen, France, 14076
GSK Clinical Trials Call Center
Calais Cedex, France, 62107
GSK Clinical Trials Call Center
Strasbourg, France, 67091
GSK Clinical Trials Call Center
Vesoul, France, 70014
Germany
GSK Clinical Trials Call Center
Heidelberg, Baden-Wurttemberg, Germany, 69126
GSK Clinical Trials Call Center
Ebensfeld, Bayern, Germany, 96250
GSK Clinical Trials Call Center
Gauting, Bayern, Germany, 82131
GSK Clinical Trials Call Center
Grosshansdorf, Germany, 22927
Honduras
GSK Clinical Trials Call Center
Tegucigalpa, Honduras
Hungary
GSK Clinical Trials Call Center
Budapest, Hungary, 1529
GSK Clinical Trials Call Center
Hungary, Hungary, 8900
Italy
GSK Clinical Trials Call Center
Genova, Liguria, Italy, 16132
GSK Clinical Trials Call Center
Lazio, Italy, 149
GSK Clinical Trials Call Center
Roma, Italy, 149
GSK Clinical Trials Call Center
Roma, Italy, 184
Jamaica
GSK Clinical Trials Call Center
Kingston, Jamaica
Korea, Republic of
GSK Clinical Trials Call Center
Seoul, Korea, Republic of, 120-752
GSK Clinical Trials Call Center
Seoul, Korea, Republic of, 110-744
Lithuania
GSK Clinical Trials Call Center
Kaunas, Lithuania, LT-45434
GSK Clinical Trials Call Center
Vilnius, Lithuania, LT-08660
Mexico
GSK Clinical Trials Call Center
Chihuahua, Mexico, 31000
GSK Clinical Trials Call Center
Guadalajara, Mexico, 45170
GSK Clinical Trials Call Center
Guadalajara, Mexico, 44280
GSK Clinical Trials Call Center
Mexico City, Mexico, 14000
Netherlands
GSK Clinical Trials Call Center
Apeldoorn, Netherlands, 7334 DZ
GSK Clinical Trials Call Center
Arnheim, Netherlands, 6815 AD
GSK Clinical Trials Call Center
Ede, Netherlands, 6716 RP
GSK Clinical Trials Call Center
Harderwijk, Netherlands, 3844 DG
GSK Clinical Trials Call Center
Nieuwegein, Netherlands, 3435 CM
New Zealand
GSK Clinical Trials Call Center
Hamilton, New Zealand, 2001
GSK Clinical Trials Call Center
Wellington South, New Zealand, 6002
Norway
GSK Clinical Trials Call Center
Oslo, Norway, 407
Panama
GSK Clinical Trials Call Center
Panama, Panama
Poland
GSK Clinical Trials Call Center
Gdansk, Poland, 80-211
GSK Clinical Trials Call Center
Kielce, Poland, 25-640
Puerto Rico
GSK Clinical Trials Call Center
Ponce, Puerto Rico, 716
Russian Federation
GSK Clinical Trials Call Center
Moscow, Russian Federation, 115 478
GSK Clinical Trials Call Center
Moscow, Russian Federation, 107 055
GSK Clinical Trials Call Center
Moscow Region, Russian Federation, 143 423
Singapore
GSK Clinical Trials Call Center
Singapore, Singapore, 119074
Slovakia
GSK Clinical Trials Call Center
Banska Bystrica, Slovakia, 975 17
GSK Clinical Trials Call Center
Bratislava, Slovakia, 825 56
GSK Clinical Trials Call Center
Kosice, Slovakia, 041 09
GSK Clinical Trials Call Center
Nitra, Slovakia, 949 88
South Africa
GSK Clinical Trials Call Center
Johannesburg, Gauteng, South Africa, 2193
Spain
GSK Clinical Trials Call Center
Lerida, Spain, 25198
GSK Clinical Trials Call Center
Valencia, Spain, 46009
Taiwan
GSK Clinical Trials Call Center
Taipei, Taiwan, 105
GSK Clinical Trials Call Center
Taipei, Taiwan, 100
United Kingdom
GSK Clinical Trials Call Center
Aberdeen, Aberdeenshire, United Kingdom, AB25 2ZD
GSK Clinical Trials Call Center
Nottingham, Nottinghamshire, United Kingdom, NG5 1PB
GSK Clinical Trials Call Center
Glasgow, United Kingdom, G4 0SF
GSK Clinical Trials Call Center
Leeds, United Kingdom, LS16 6QB
GSK Clinical Trials Call Center
Leicester, United Kingdom, LE1 5WW
GSK Clinical Trials Call Center
Poole, United Kingdom, BH15 2JB
Sponsors and Collaborators
GlaxoSmithKline
Investigators
Study Director: GSK Clinical Trial, MD GlaxoSmithKline
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00043927     History of Changes
Other Study ID Numbers: 104864-A/389
Study First Received: August 14, 2002
Last Updated: August 20, 2013
Health Authority: United States: Food and Drug Administration
United Kingdom: Medicines and Healthcare Products Regulatory Agency

Keywords provided by GlaxoSmithKline:
Chemotherapy-naive
Small Cell Lung Cancer
SCLC
Extensive disease
ED
topotecan
Hycamtin
oral

Additional relevant MeSH terms:
Lung Neoplasms
Small Cell Lung Carcinoma
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms
Cisplatin
Etoposide
Topotecan
Antineoplastic Agents
Therapeutic Uses
Pharmacologic Actions
Radiation-Sensitizing Agents
Antineoplastic Agents, Phytogenic
Topoisomerase II Inhibitors
Topoisomerase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Topoisomerase I Inhibitors

ClinicalTrials.gov processed this record on October 01, 2014